The relationship between right atrial wall inflammation and poor prognosis of atrial fibrillation based on 18F-FDG positron emission tomography/computed tomography

Peng Wan; Wenji Yu; Lishang Zhai; Bo Qian; Feifei Zhang; Bao Liu; Jianfeng Wang; Xiaoliang Shao; Yunmei Shi; Qi Jiang; Mengfei Wang; Shan Shao; Yuetao Wang

doi:10.21037/qims-23-1129

The relationship between right atrial wall inflammation and poor prognosis of atrial fibrillation based on ¹⁸F-FDG positron emission tomography/computed tomography

Quant Imaging Med Surg. 2024 Feb 1;14(2):1369-1382. doi: 10.21037/qims-23-1129. Epub 2024 Jan 2.

Authors

Peng Wan^#¹, Wenji Yu^#^{2

3}, Lishang Zhai¹, Bo Qian¹, Feifei Zhang^{2

3}, Bao Liu^{2

3}, Jianfeng Wang^{2

3}, Xiaoliang Shao^{2

3}, Yunmei Shi^{2

3}, Qi Jiang¹, Mengfei Wang¹, Shan Shao^#¹, Yuetao Wang^#^{2

3}

Affiliations

¹ Department of Cardiology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
² Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, China.
³ Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University, Changzhou, China.

^# Contributed equally.

Abstract

Background: Atrial fibrillation (AF) has been identified to increase stroke risk, even after oral anticoagulants (OACs), and the recurrence rate is high after radiofrequency catheter ablation (RFCA). Inflammation is an essential factor in the occurrence and persistence of AF. ¹⁸F-fluorodeoxyglucose (¹⁸F-FDG) positron emission tomography/computed tomography (PET/CT) is an established molecular imaging modality to detect local inflammation. We aimed to investigate the relationship between atrial inflammatory activity and poor prognosis of AF based on ¹⁸F-FDG PET/CT.

Methods: A total of 204 AF patients including 75 with paroxysmal AF (ParAF) and 129 with persistent AF (PerAF) who underwent PET/CT before treatment were enrolled in this prospective cohort study. Clinical data, electrocardiograph (ECG), echocardiography, and cardiac ¹⁸F-FDG uptake were collected. Follow-up information was obtained from patient clinical case notes or telephone reviews, with the starting point being the time of PET/CT scan. The follow-up deadline was either the date of AF recurrence after RFCA, new-onset stroke, or May 2023. Cox proportional hazards regression models were used to identify predictors of poor prognosis and hazard ratios (HRs) with 95% confidence intervals (CIs) was calculated.

Results: Median follow-up time was 29 months [interquartile range (IQR), 22-36 months]. Poor prognosis occurred in 52 patients (25.5%), including 34 new-onset stroke patients and 18 recrudescence after RFCA. The poor prognosis group had higher congestive heart failure, hypertension, age ≥75 years (doubled), diabetes mellitus, prior stroke or transient ischemic attack (TIA) or thromboembolism (doubled), vascular disease, age 65-74 years, sex category (female) (CHA2DS2-VASc) score [3.0 (IQR, 1.0-3.75) vs. 2.0 (IQR, 1.0-3.0), P=0.01], right atrial (RA) wall maximum standardized uptake value (SUV_max) (4.13±1.82 vs. 3.74±1.58, P=0.04), higher percentage of PerAF [39 (75.0%) vs. 90 (59.2%), P=0.04], left atrial (LA) enlargement [45 (86.5%) vs. 104 (68.4%), P=0.01], and RA wall positive FDG uptake [40 (76.9%) vs. 79 (52.0%), P=0.002] compared with the non-poor prognosis group. Univariate and multivariate Cox proportional hazard regression analysis concluded that only CHA2DS2-VASc score (HR, 1.29; 95% CI: 1.06-1.57; P=0.01) and RA wall positive FDG uptake (HR, 2.68; 95% CI: 1.10-6.50; P=0.03) were significantly associated with poor prognosis.

Conclusions: RA wall FDG positive uptake based on PET/CT is tightly related to AF recurrence after RFCA or new-onset stroke after antiarrhythmic and anticoagulation treatment.

Keywords: Atrial fibrillation (AF); inflammation; positron emission tomography/computed tomography (PET/CT); recurrence; stroke.